Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study.
Autorzy:
Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK. Hawkey C; Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, UK. Hind D; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. Swaby L; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. . Mellor K; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. Emsley R; Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Mandefield L; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. Lee E; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. Badoglio M; European Society for Blood and Marrow Transplantation, Paris, France. Polge E; European Society for Blood and Marrow Transplantation, Paris, France. Labopin M; European Society for Blood and Marrow Transplantation, Paris, France. Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK. Pockley AG; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK. FouldsGA; John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK. Lobo A; Department of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UK. Travis S; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Parkes M; Department of Medicine, University of Cambridge, Cambridge, UK. Satsangi J; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Papaioannou D; Clinical Trials Research Unit, ScHARR, University of Sheffield, Sheffield, UK. Lindsay JO; Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
Tumor imaging and targeting potential of an Hsp70-derived 14-mer peptide.
Autorzy:
Gehrmann M; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Stangl S; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. FouldsGA; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom. Oellinger R; Medical Department II, Translational Gastroenterological Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Breuninger S; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Rad R; Medical Department II, Translational Gastroenterological Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Pockley AG; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom. Multhoff G; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Clinical Cooperation Group (CCG) ''Innate Immunity in Tumor Biology'', Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Aug 28; Vol. 9 (8), pp. e105344. Date of Electronic Publication: 2014 Aug 28 (Print Publication: 2014).
Immunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme B.
Autorzy:
Gehrmann M; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, and Clinical Cooperation Group (CCG) 'Innate Immunity in Tumor Biology', Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany. Stangl S Kirschner A FouldsGA Sievert W Doss BT Walch A Pockley AG Multhoff G
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (7), pp. e41341. Date of Electronic Publication: 2012 Jul 19.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
